P539: PROGNOSTIC RELEVANCE OF MINIMAL RESIDUAL DISEASE IN THERAPY RELATED AND SECONDARY ACUTE MYELOID LEUKEMIA RECEIVING CPX-351 OR FLUDARABINE-BASED INDUCTION.
F. Guolo,
P. Minetto,
C. Riva,
F. Parodi,
M. Miglino,
E. Tedone,
N. Colombo,
E. Carminati,
C. Nurra,
A. Cagnetta,
M. Cea,
R. M. Lemoli
Affiliations
F. Guolo
1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino
P. Minetto
1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino
C. Riva
1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino
F. Parodi
2 University of Genoa
M. Miglino
1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino
E. Tedone
3 Flow Cytometry Unit, Department of Pathological Anatomy
N. Colombo
3 Flow Cytometry Unit, Department of Pathological Anatomy
E. Carminati
4 Molecular Biology Unit, Department of Pathological Anatomy, IRCCS Ospedale Policlinico San Martino, GENOVA, Italy
C. Nurra
4 Molecular Biology Unit, Department of Pathological Anatomy, IRCCS Ospedale Policlinico San Martino, GENOVA, Italy
A. Cagnetta
1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino
M. Cea
1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino
R. M. Lemoli
1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino
